![Diego A. Rey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Diego A.
Rey was the Chief Technology Officer of GeneWeave Biosciences, Inc. which was founded in 2007.
Mr. Rey is also the founder of Endpoint Health, Inc.
Postes actifs de Diego A. Rey
Sociétés | Poste | Début |
---|---|---|
Endpoint Health, Inc.
![]() Endpoint Health, Inc. Miscellaneous Commercial ServicesCommercial Services Endpoint Health, Inc. is a medicine company. The firm?s novel approach combines proprietary biomarkers and patient data with diagnostics and artificial intelligence to guide therapy choice and improve patient outcomes. The company is headquartered in Palo Alto, CA. | Fondateur | - |
Anciens postes connus de Diego A. Rey
Sociétés | Poste | Fin |
---|---|---|
GeneWeave Biosciences, Inc.
![]() GeneWeave Biosciences, Inc. Medical/Nursing ServicesHealth Services GeneWeave Biosciences, Inc. developed a platform for detecting infectious diseases. It developed clinical microbiology with diagnostic solutions to aid healthcare providers in the treatment of drug-resistant bacteria. The company was founded by Jason Springs, Diego A. Rey and Leo Teixeira in 2007 and was headquartered in Los Gatos, CA. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
GeneWeave Biosciences, Inc.
![]() GeneWeave Biosciences, Inc. Medical/Nursing ServicesHealth Services GeneWeave Biosciences, Inc. developed a platform for detecting infectious diseases. It developed clinical microbiology with diagnostic solutions to aid healthcare providers in the treatment of drug-resistant bacteria. The company was founded by Jason Springs, Diego A. Rey and Leo Teixeira in 2007 and was headquartered in Los Gatos, CA. | Health Services |
Endpoint Health, Inc.
![]() Endpoint Health, Inc. Miscellaneous Commercial ServicesCommercial Services Endpoint Health, Inc. is a medicine company. The firm?s novel approach combines proprietary biomarkers and patient data with diagnostics and artificial intelligence to guide therapy choice and improve patient outcomes. The company is headquartered in Palo Alto, CA. | Commercial Services |